Clinical Trials Logo

Filter by:
NCT ID: NCT05650333 Completed - Alopecia Areata Clinical Trials

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

Start date: March 2, 2023
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the pharmacokinetics (how the medicine is changed and eliminated from your body after you take it) and pharmacodynamics (effects of the medicine in the body) of the study medicine (called Ritlecitinib) in children of 6 to <12 years of age with Alopecia Areata, a condition of scalp hair loss. 12 children with alopecia areata will be participating in this study. All participants will receive study medicine with a dose of 20 milligram (mg) orally once daily for 7 days. 5 blood samples will be collected on day 7 for pharmacokinetic evaluation and 2 blood samples each at screening and on Day 7 will be collected for pharmacodynamic evaluation. Participants will take part in the study for about 10 weeks.

NCT ID: NCT05650190 Completed - Myopia Clinical Trials

Spectacle Lens Visual Acuity Assessments Study

CEDAR
Start date: December 8, 2022
Phase: N/A
Study type: Interventional

This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.

NCT ID: NCT05650008 Completed - Clinical trials for Left Ventricular Dysfunction

Effects of Intrathecal Local Anesthetics on Left Ventricular Global Longitudinal Strain

Start date: February 1, 2023
Phase:
Study type: Observational

The objective of this study is to assess the effects of intrathecal local anesthetics on left ventricular global longitudinal strain (LVGLS) using transthoracic echocardiography (TTE).

NCT ID: NCT05649449 Completed - Mental Disorder Clinical Trials

Testing Self-Directed Care in Florida

Start date: September 5, 2017
Phase: N/A
Study type: Interventional

This study tests a psychosocial intervention called mental health self-directed care by assessing its impact on recovery, mental health status, rehabilitation outcomes, and service costs in the state of Florida.

NCT ID: NCT05649241 Completed - Smoking Cessation Clinical Trials

QuitAid Pilot Feasibility Trial

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

Adult smokers were recruited through an independent pharmacy in rural Appalachia and were randomized to 1 of 8 treatments, including medication and/or therapy from the pharmacist, to help quit smoking.

NCT ID: NCT05649228 Completed - Pain Management Clinical Trials

Thermosensitivity of a Topical Palmitated Formulation of Capsaicin

Start date: December 13, 2022
Phase: Early Phase 1
Study type: Interventional

This is a study of the effects of capsaicin, the ingredient that makes hot peppers hot. Capsaicin is currently used in topical ointments to provide temporary relief of minor aches and joint pain associated with arthritis, simple backache, strains, and sprains. This is a pilot research study that compares the potential of two different capsaicin creams to cause irritation or burning sensation when a small amount (about the size of a quarter) is applied to each forearm of a participant. The amount of capsaicin used in the creams is the same as those found in over-the-counter capsaicin products. The test creams are experimental.

NCT ID: NCT05649189 Completed - Food Addiction Clinical Trials

Differences in Length of Telomere in Food Addicted vs Non Food Addicted Persons

Start date: October 17, 2021
Phase:
Study type: Observational

The purpose of this descriptive study is to examine telomere length between two groups of people, those with and those without food addiction and identify possible relationships that may play a role in food addiction, it's behaviors and consequences. Research subjects would be adults age 19-70. They would be recruited from the Rural Nebraska Panhandle population. All COVID precautions will be enforced. Human subjects safety plans will be in place for this study.Eligibility: YaleFAS-2 Food Addiction Scale will be used to screen for presence or absence of food addiction. AT a later time, Eligible persons will be given the research consent form to read through and determine if they want to become a participant. If so, they will be consented. The participants will then be assigned an identification number to maintain confidentiality. Intervention: Participants will be given a Oragene saliva DNA collection kit to use and return to investigators. Evaluation:The Oragene saliva DNA collection kit will then be sent in for telomere length testing. Telomere Results will be correlated with food addiction diagnoses and behaviors to identify potential relationships. Follow up: Publication of results

NCT ID: NCT05648773 Completed - Clinical trials for Booster Message + Financial Incentive

COVID-19 Booster Incentives

Start date: December 8, 2022
Phase: N/A
Study type: Interventional

The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).

NCT ID: NCT05647824 Completed - Diabetes Mellitus Clinical Trials

User Performance of the TV4 BGMS

Start date: February 5, 2020
Phase:
Study type: Observational

Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also called study staff).

NCT ID: NCT05647759 Completed - Heart Failure Clinical Trials

Rural HEART Camp Connect: A Feasibility Study

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

This study builds on the tested and refined HEART Camp intervention which has been shown to improve long-term adherence to exercise in individuals diagnosed with heart failure. HEART Camp Connect enhances HEART Camp by delivering the coaching via videoconference and providing access to hospital-based exercise facilities and online exercise programming. This study is a prospective, single-group, repeated measures feasibility study with 4 data collection points (baseline, 4, 8, and 12 weeks). Study variables including instruments will be collected at baseline, 4, and 8 weeks. Participants will also be asked to participate in a 30-45 minute interview at 12 weeks.